(19)
(11) EP 2 630 498 A2

(12)

(88) Date of publication A3:
19.07.2012

(43) Date of publication:
28.08.2013 Bulletin 2013/35

(21) Application number: 11835211.1

(22) Date of filing: 21.10.2011
(51) International Patent Classification (IPC): 
G01N 33/574(2006.01)
G01N 30/00(2006.01)
G01N 33/68(2006.01)
G01N 33/543(2006.01)
(86) International application number:
PCT/US2011/057271
(87) International publication number:
WO 2012/054824 (26.04.2012 Gazette 2012/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 22.10.2010 US 406044 P

(71) Applicant: Vermillion, Inc.
Austin, TX 78738 (US)

(72) Inventors:
  • HOGDALL, Estrid
    2730 Herlev  (DK)
  • FUNG, Eric, T.
    Mountain View, CA 94043 (US)
  • CHRISTENSEN, Ib, Jarle
    2100 Copenhagen (DK)
  • HOGDALL, Claus
    2100 Copenhagen (DK)

(74) Representative: Hiebl, Inge Elisabeth 
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München
80539 München (DE)

   


(54) PROGNOSTIC BIOMARKERS IN PATIENTS WITH OVARIAN CANCER